Hungarian Conservative

A new VR-assisted surgical procedure was first performed in January at the Paediatric Clinic of Semmelweis University, involving a seven-year-old child suffering from a malignant tumour of the sympathetic nervous system. Prior to the operation, the tumour and its surroundings were virtually visualized through a VR headset, providing a precise image of the neuroblastoma’s location.

A study led by Csaba Kerepesi, a researcher at the Artificial Intelligence Research Laboratory of the HUN-REN Computer and Automation Research Institute, demonstrated that the occurrence of autoimmune side effects during cancer immunotherapy correlates with the tumour’s immune microenvironment, particularly the emergence of new antigens during tumour mutations, and the number of CD8+ T-cells infiltrating the tumour.

The event will be taking place from 9–11 November at the Budapest Congress Center. The latest innovations will be discussed by experts in all fields of oncology, from surgical, medicinal, and radiation therapy to the all-important prevention and screening.

The effectiveness of the Hungarian-developed candidate drug has been confirmed by numerous studies conducted on various human cancer cell lines, and animal experiments on hormone-independent aggressive breast cancer models also clearly demonstrate its exceptional efficacy.

In the past decade, Hungary has been able to reach the EU average in several respects in the fields of oncology, states Prof. Csaba Polgár, Director General of the National Institute of Oncology. An interview about ‘devastating’ OECD statistics, the Hungarian cancer strategy and the suspended EU funds.